The AGE Research Group’s vision is to improve lives through world-class research in ageing, sarcopenia and multiple long-term conditions.
OUR RESEARCH
We lead interdisciplinary research on ageing across the translational spectrum. Through the design and delivery of innovative deep phenotyped observational and experimental ageing studies we are making advances in the prevention, diagnosis and treatment of common age-related conditions, including sarcopenia and multiple long-term conditions (MLTC). Our focus on translation ensures that the research evidence we generate has wide-ranging impacts on practice and policy and delivers benefits for individuals and society.
LATEST NEWS
-
![]()
MASS Lifecourse enters new phase of discovery
24 October 2025
Participants in one of the AGE Research Group’s flagship studies are being invited to take part in follow-up assessments, five to six years after their first visits.
-
![]()
New UK sarcopenia survey data published
14 October 2025
Members of the AGE Research Group have published a new paper in the journal European Geriatric Medicine reporting on current practice in the management and diagnosis of sarcopenia in the UK.
-
![]()
BEPOP Wave 2 Report Launched
28 August 2025
BEPOP (Benchmarking Exercise Programme for Older People) is a national quality improvement, benchmarking and feedback initiative to improve the quality of resistance exercise training for older people living with frailty or sarcopenia.
-
![]()
Celebrating a Milestone in Ageing Research
04 July 2025
In October 2024, Professor Avan Aihie Sayer was honoured to deliver the Harveian Oration at the Royal College of Physicians. The oration is now published.
TEAM SCIENCE
Our AGE Research Group members have expertise in a wide range of disciplines including geriatric medicine, life course epidemiology, trials for older people, gerontology, physiology, sport and exercise science and social sciences. Our professional services team members bring complementary expertise in PPIE, project delivery, operations and events, ensuring our research runs smoothly and has real impact.
We take a team science approach to our research and this harnesses the value of our interdisciplinarity, intentionally fostering a culture of generosity, trust and support.
PUBLIC PARTNERSHIPS
We place patients and the public at the centre of our research, from design to dissemination.
PARTNERSHIPS AND COLLABORATIONS
We take a collaborative approach to our research and actively seek opportunities to work in partnership with other academic groups and organisations, including industry, with a focus on maximising impact and patient and public benefit.
RESEARCH CAPACITY DEVELOPMENT
We are committed to developing the next generation of leaders in academic geriatric medicine and wider ageing research.
@newcastleage.bsky.social
linkedin.com/company/newcastle-age